SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,781.89 -251.89
( -0.34%)

Global Indices

Nasdaq

51,633.03 -58.07
(-0.11%)

Dow Jones

7,740.63 -85.82
(-1.10%)

Hang Seng

67,780.30 2.78
(0.00%)

Nikkei 225

10,730.66 80.33
(0.75%)

Forex

USD-INR

95.69 -0.76
(-0.79%)

EUR-INR

107.00 -1.04
(-0.96%)

GBP-INR

126.57 -1.05
(-0.82%)

JPY-INR

0.60 -0.01
(-0.89%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

49.87

1202.85

EPS(TTM)

Face Value()

Div & Yield %

20.47

0.05

Back

Can Fin Homes standalone net profit rises 19.63% in the June 2026 quarter

Jul 20,2026

Net profit of Can Fin Homes rose 19.63% to Rs 267.82 crore in the quarter ended June 2026 as against Rs 223.87 crore during the previous quarter ended June 2025. Sales rose 7.43% to Rs 1096.15 crore in the quarter ended June 2026 as against Rs 1020.33 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1096.15	1020.33	7
OPM %	91.29	91.08	-
PBDT	341.35	281.09	21
PBT	338.51	277.63	22
NP	267.82	223.87	20

72,781.89 -251.89 ( -0.34%)

51,633.03 -58.07 (-0.11%)

7,740.63 -85.82 (-1.10%)

67,780.30 2.78 (0.00%)

10,730.66 80.33 (0.75%)

95.69 -0.76 (-0.79%)

107.00 -1.04 (-0.96%)

126.57 -1.05 (-0.82%)

0.60 -0.01 (-0.89%)